OraSure Technologies Inc (OSUR) is a publicly traded Healthcare sector company. As of May 21, 2026, OSUR trades at $3.07 with a market cap of $207.23M and a P/E ratio of -2.96. OSUR moved -0.65% today. Year to date, OSUR is +24.29%; over the trailing twelve months it is +9.64%. Its 52-week range spans $2.08 to $4.60. Rallies surfaces OSUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in OSUR news today?
OraSure Q1 revenue $27.9 million beats guidance; gross margin rises to 42.3%: OraSure reported Q1 revenue of $27.9 million, down 7% year-over-year but above its guidance midpoint, with core revenues nearly flat at $27.9 million. Gross margin expanded to 42.3% while GAAP operating loss widened to $23.3 million; cash totaled $177 million after a $5 million share buyback.
Boyd Steven Kyle bought 25.00K (~$74.75K) on May 14, 2026.
Boyd Steven Kyle bought 25.00K (~$75.50K) on May 13, 2026.
Boyd Steven Kyle bought 25.00K (~$74.50K) on May 12, 2026.
OSUR Analyst Consensus
OSUR analyst coverage data. Average price target: $0.00.
Common questions about OSUR
What changed in OSUR news today?
OraSure Q1 revenue $27.9 million beats guidance; gross margin rises to 42.3%: OraSure reported Q1 revenue of $27.9 million, down 7% year-over-year but above its guidance midpoint, with core revenues nearly flat at $27.9 million. Gross margin expanded to 42.3% while GAAP operating loss widened to $23.3 million; cash totaled $177 million after a $5 million share buyback.
Does Rallies summarize OSUR news?
Yes. Rallies summarizes OSUR news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is OSUR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OSUR. It does not provide personalized investment advice.
